<span style="color: #222222;">Central Drugs Standard Control Organisation has given approval to Corbevax vaccine, Covovax vaccine, and anti-viral drug Molnupiravir for restricted use in emergency situations. In a series of tweets, Union Health Minister Mansukh Mandaviya said, Corbevax vaccine is India's first indigenously developed RBD protein sub-unit vaccine against COVID-19, made by Hyderabad-based firm Biological-E.  It is the third vaccine developed in India.  <br />''<br />''The Nanoparticle Vaccine, Covovax, will be manufactured by Pune-based firm Serum Institute of India.<br />''<br />''Mr. Mandaviya said, Molnupiravir will now be manufactured in the country by 13 companies for restricted use under emergency situation for the treatment of adult patients with COVID-19 and who have a high risk of progression of the disease.<br />''<br />''He added that Prime Minister Narendra Modi led the battle against COVID-19 from the front and all these approvals will further strengthen the global fight against the pandemic.<br />''<br />''In an interaction with All India Radio News, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunization Dr. N K Arora said that the approval of these two vaccines and anti-viral drugs is encouraging news for the Covid vaccination campaign.</span>